Cellectis
CLLS
64 hedge funds and large institutions have $137M invested in Cellectis in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 28 increasing their positions, 15 reducing their positions, and 12 closing their positions.
87% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 15
0.68% less ownership
Funds ownership: 31.65% → 30.97% (-0.68%)
9% less funds holding
Funds holding: 70 → 64 (-6)
35% less capital invested
Capital invested by funds: $210M → $137M (-$72.8M)
50% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$6.09M |
| 2 |
Capital International Investors
Los Angeles,
California
|
+$3.89M |
| 3 |
Morgan Stanley
New York
|
+$2.71M |
| 4 |
Millennium Management
New York
|
+$1.96M |
| 5 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$1.84M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$12.5M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$10.1M |
| 3 |
Lazard Asset Management
New York
|
-$2.38M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.58M |
| 5 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$1.18M |
CLLS Hedge Fund Activity: Q3 2019 in Review
64 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q3 2019, worth a combined $137M — down 35% from $210M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of CLLS and 6 opened new positions — a net loss of 6 holders — while 15 trimmed existing stakes and 28 added.
The largest buyer was Citadel Advisors, adding an estimated $6.09M. The largest seller was Armistice Capital, exiting entirely with an estimated $12.5M sold.
- 64 institutional investors held Cellectis (CLLS) as of Q3 2019, down from 70 in Q2 2019.
- Funds reported $137M of Cellectis stock for Q3 2019, down 35% quarter-over-quarter.
- 6 funds opened new Cellectis positions in Q3 2019 and 12 closed out, a net change of -6 holders.
- The largest Cellectis buyer in Q3 2019 was Citadel Advisors, an estimated $6.09M added.
- The largest Cellectis seller in Q3 2019 was Armistice Capital, an estimated $12.5M sold.
Based on aggregated 13F filings for Q3 2019.